🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a safety, tolerability, pharmacokinetic and efficacy study in subje...
Status
Recruiting
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2021-09-09
Trial ID
NCT04691661
Treatments Being Tested
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to ...
Status
Completed
Location
Severance Hospital
Start Date
2024-07-22
Trial ID
NCT06461078
Treatments Being Tested
The purpose of this study is to determine whether radotinib is effective an...
Status
Unknown
Location
Ulsan University Hospital
Start Date
2015-04
Trial ID
NCT02422719
Treatments Being Tested
The goal of this observational study is to learn about the efficacy and saf...
Status
Recruiting
Location
Hallym University Sacred Heart Hosptial
Start Date
2024-10-24
Trial ID
NCT06665412
Treatments Being Tested
This study is an extension study (prospective observational study) of 'IDEA...
Status
Withdrawn
Location
Seoul National University Bundang Hospital
Start Date
2014-10
Trial ID
NCT02421926
Treatments Being Tested
In a multinational, multicenter, single-arm, open-label and Phase III Radot...
Status
Recruiting
Location
Territorial State Budgetary Institution
Start Date
2018-06-25
Trial ID
NCT03459534
Treatments Being Tested
In this study, the efficacy and safety of two radotinib doses, 300 mg twice...
Status
Completed
Location
Local Institution
Start Date
2011-08
Trial ID
NCT01511289
This is a Phase III, multi-center, open-label, parallel, 2-arm, randomized ...
Status
Active Not Recruiting
Location
Peking University People's Hospital(北京大学人民医院)
Start Date
2018-12-28
Trial ID
NCT03722420
A Phase I/II multicenter study of IY5511HCl in Philadelphia chromosome posi...
Status
Completed
Location
Local institution
Start Date
2008-07
Trial ID
NCT01602952
Treatments Being Tested